How much will NATCO Pharma be worth in 2025–2030? Check out expert forecasts, price targets, and predictions for NATCO Pharma based on technical analysis.
The current price of NATCO Pharma on the NSE is ₹818.80. According to our forecast, the value of NATCO Pharma shares will rise by 74.26% and reach ₹1,426.84 per share by 2025. As per our technical indicators, the current sentiment is Bearish, while the Fear & Greed Index is showing a score of 38.98 (Fear). Currently, NATCO Pharma is trading below the 200-day simple moving average and the 50-day simple moving average, while the RSI is in the neutral zone (30-70). Based on the NATCO Pharma stock forecast, now is the bad time to buy NATCO Pharma shares.
NATCO Pharma Share Profit Calculator
NATCO Pharma Share Historical Stats
| Year | Avg. Price | Min. Price | Max. Price | Change |
|---|---|---|---|---|
| 2024 | ₹1,193.11 | ₹805.00 | ₹1,639.00 | 71.88% |
| 2023 | ₹694.13 | ₹502.00 | ₹928.00 | -1.47% |
| 2022 | ₹704.52 | ₹545.00 | ₹944.00 | -23.99% |
| 2021 | ₹926.85 | ₹771.50 | ₹1,189.00 | 26.86% |
| 2020 | ₹730.61 | ₹402.55 | ₹996.00 | 27.56% |
| 2019 | ₹572.74 | ₹480.00 | ₹709.80 | -27.53% |
| 2018 | ₹790.33 | ₹636.00 | ₹1,046.95 | -8.91% |
| 2017 | ₹867.68 | ₹581.35 | ₹1,090.00 | 57.51% |
| 2016 | ₹550.87 | ₹390.00 | ₹702.65 | 26.97% |
| 2015 | ₹433.86 | ₹266.00 | ₹596.85 | 106.04% |
| 2014 | ₹210.57 | ₹130.00 | ₹318.00 | 93.42% |
| 2013 | ₹108.87 | ₹80.61 | ₹168.00 | 52.61% |
| 2012 | ₹71.33 | ₹46.30 | ₹101.36 | 37.51% |
| 2011 | ₹51.87 | ₹38.99 | ₹69.80 | 24.79% |
| 2010 | ₹41.57 | ₹21.90 | ₹71.40 | 147.30% |
NATCO Pharma Share Price Target 2025
According to our latest price forecast produced and curated by a team of experienced analysts, NATCO Pharma share is expected to fluctuate between ₹1,095.34 and ₹1,426.84 in 2025. The average price target for NATCO Pharma share in 2025 is ₹1,244.90, which would be a 52.04% increase from the current price.
- At the beginning of 2025, the NATCO Pharma share price target could be around ₹1,208.83.
- By mid-2025, the price target might reach approximately ₹1,156.87.
- By the end of 2025, the price target for NATCO Pharma is expected to be around ₹1,426.84.
| Month | Price Target |
| January 2025 | ₹1,208.83 |
| February 2025 | ₹1,095.34 |
| March 2025 | ₹1,108.67 |
| April 2025 | ₹1,165.30 |
| May 2025 | ₹1,162.43 |
| June 2025 | ₹1,156.87 |
| July 2025 | ₹1,208.90 |
| August 2025 | ₹1,275.63 |
| September 2025 | ₹1,342.20 |
| October 2025 | ₹1,385.47 |
| November 2025 | ₹1,402.38 |
| December 2025 | ₹1,426.84 |
NATCO Pharma Share Price Target 2026
After the analysis of the prices of NATCO Pharma share in previous years, it is estimated that in 2026, the minimum price of NATCO Pharma will be ₹1,438.27 while the maximum price may reach ₹1,612.76. On average, the trading price might be ₹1,508.71 in 2026, which is about 84.26% higher than current price.
- At the beginning of 2026, the NATCO Pharma share price target could be around ₹1,438.27.
- By mid-2026, the price target might reach approximately ₹1,498.67.
- By the end of 2026, the price target for NATCO Pharma is expected to be around ₹1,612.76.
| Month | Price Target |
| January 2026 | ₹1,438.27 |
| February 2026 | ₹1,442.93 |
| March 2026 | ₹1,445.16 |
| April 2026 | ₹1,456.72 |
| May 2026 | ₹1,472.38 |
| June 2026 | ₹1,498.67 |
| July 2026 | ₹1,515.23 |
| August 2026 | ₹1,525.90 |
| September 2026 | ₹1,542.37 |
| October 2026 | ₹1,568.84 |
| November 2026 | ₹1,585.29 |
| December 2026 | ₹1,612.76 |
NATCO Pharma Share Price Target 2027
Figw Analysts estimate that the value of NATCO Pharma could reach a low of ₹1,622.89 and a high of around ₹1,868.73 by 2027. Overall, NATCO Pharma is expected to trade at an average price of ₹1,711.50 during the year.
- At the beginning of 2027, the NATCO Pharma share price target could be around ₹1,625.43.
- By mid-2027, the price target might reach approximately ₹1,685.83.
- By the end of 2027, the price target for NATCO Pharma is expected to be around ₹1,868.73.
| Month | Price Target |
| January 2027 | ₹1,625.43 |
| February 2027 | ₹1,622.89 |
| March 2027 | ₹1,625.34 |
| April 2027 | ₹1,645.92 |
| May 2027 | ₹1,662.17 |
| June 2027 | ₹1,685.83 |
| July 2027 | ₹1,702.46 |
| August 2027 | ₹1,725.20 |
| September 2027 | ₹1,745.94 |
| October 2027 | ₹1,792.67 |
| November 2027 | ₹1,835.28 |
| December 2027 | ₹1,868.73 |
NATCO Pharma Share Price Target 2028
According to our latest forecast for 2028, the lowest price target for NATCO Pharma is ₹1,872.91, while the highest is ₹2,125.76. On average, NATCO Pharma is expected to trade around ₹1,964.93.
- At the beginning of 2028, the NATCO Pharma share price target could be around ₹1,872.91.
- By mid-2028, the price target might reach approximately ₹1,945.80.
- By the end of 2028, the price target for NATCO Pharma is expected to be around ₹2,125.76.
| Month | Price Target |
| January 2028 | ₹1,872.91 |
| February 2028 | ₹1,875.34 |
| March 2028 | ₹1,885.67 |
| April 2028 | ₹1,902.83 |
| May 2028 | ₹1,922.04 |
| June 2028 | ₹1,945.80 |
| July 2028 | ₹1,962.34 |
| August 2028 | ₹1,972.90 |
| September 2028 | ₹1,985.47 |
| October 2028 | ₹2,042.83 |
| November 2028 | ₹2,085.30 |
| December 2028 | ₹2,125.76 |
NATCO Pharma Share Price Target 2029
According to our latest forecast for 2029, the lowest price target for NATCO Pharma is ₹2,168.34, while the highest is ₹2,412.08. On average, NATCO Pharma is expected to trade around ₹2,260.60.
- At the beginning of 2029, the NATCO Pharma share price target could be around ₹2,168.34.
- By mid-2029, the price target might reach approximately ₹2,245.73.
- By the end of 2029, the price target for NATCO Pharma is expected to be around ₹2,412.08.
| Month | Price Target |
| January 2029 | ₹2,168.34 |
| February 2029 | ₹2,182.90 |
| March 2029 | ₹2,185.47 |
| April 2029 | ₹2,192.83 |
| May 2029 | ₹2,212.16 |
| June 2029 | ₹2,245.73 |
| July 2029 | ₹2,262.89 |
| August 2029 | ₹2,275.34 |
| September 2029 | ₹2,285.00 |
| October 2029 | ₹2,328.47 |
| November 2029 | ₹2,375.83 |
| December 2029 | ₹2,412.08 |
NATCO Pharma Share Price Target 2030
According to our latest forecast for 2030, the lowest price target for NATCO Pharma is ₹2,425.73, while the highest is ₹2,742.50. On average, NATCO Pharma is expected to trade around ₹2,542.39.
- At the beginning of 2030, the NATCO Pharma share price target could be around ₹2,425.73.
- By mid-2030, the price target might reach approximately ₹2,482.83.
- By the end of 2030, the price target for NATCO Pharma is expected to be around ₹2,742.50.
| Month | Price Target |
| January 2030 | ₹2,425.73 |
| February 2030 | ₹2,435.90 |
| March 2030 | ₹2,442.34 |
| April 2030 | ₹2,452.91 |
| May 2030 | ₹2,465.47 |
| June 2030 | ₹2,482.83 |
| July 2030 | ₹2,525.16 |
| August 2030 | ₹2,568.73 |
| September 2030 | ₹2,612.89 |
| October 2030 | ₹2,655.34 |
| November 2030 | ₹2,698.90 |
| December 2030 | ₹2,742.50 |
NATCO Pharma Share Price Target from 2025 to 2030
Here is a table summarizing yearly price target of NATCO Pharma share from 2025 to 2030.
| Year | Price Target | Percent Increase |
| 2025 | ₹1,244.90 | 52.04% |
| 2026 | ₹1,508.71 | 84.26% |
| 2027 | ₹1,711.50 | 109.03% |
| 2028 | ₹1,964.93 | 139.98% |
| 2029 | ₹2,260.60 | 176.09% |
| 2030 | ₹2,542.39 | 210.50% |
NATCO Pharma Share Price Forecast for 1 year: What do Analysts Predict?
In this section, you will learn the following analyst Forecast:
- Predicted share price
- Annual revenue Forecast.
- Annual earnings per share (EPS) Forecast.
The Forecasts are made based on surveys of various financial institutions, brokerage firms, fund managers, and independent analysts, and are sourced from S&P Global Market Intelligence.
| Analyst Recommendations (12 Analysts) | |
| Buy | 45.45% |
| Hold | 18.18% |
| Sell | 36.36% |
| Overall Recommendation | Hold |
| Share Price Forecast for 1 year | |
| Current Share Price | ₹818.80 |
| Minimum Forecast | ₹710.00 |
| Maximum Forecast | ₹1,675.00 |
| Average Forecast | ₹1,153.17 |
| Annual Revenue Forecast | |
| 2024 | ₹46.57B |
| 2025 | ₹52.50B |
| 2026 | ₹35.55B |
| Annual earnings per share (EPS) Forecast | |
| 2024 | ₹111.12 |
| 2025 | ₹118.46 |
| 2026 | ₹47.88 |
NATCO Pharma Share Price Forecast Based on Technical Analysis
NATCO Pharma is currently in a Bearish trend according to different technical analysis indicators and moving averages, with a majority of indicators (2 Bullish, 12 Bearish, and 7 Neutral) supporting this outlook.
Moving averages and oscillators are popular tools to understand stock price trends and market behavior. SMAs and EMAs smooth out price fluctuations to identify trends over a certain amount of time. RSI and MACD are both momentum indicators that are used to identify stock momentum, overbought or oversold conditions and possible reversal points. In the tables below, you can find the values along with signals (bullish, bearish, neutral) for moving averages and oscillators.
Daily Simple Moving Average (SMA)
| Name | Value | Action |
|---|---|---|
| SMA (10) | 803.49 | Buy |
| SMA (20) | 963.62 | Sell |
| SMA (30) | 1,041.23 | Sell |
| SMA (50) | 1,146.85 | Sell |
| SMA (100) | 1,272.34 | Sell |
| SMA (200) | 1,296.44 | Sell |
Daily Exponential Moving Average (EMA)
| Name | Value | Action |
|---|---|---|
| EMA (10) | 836.02 | Sell |
| EMA (20) | 923.28 | Sell |
| EMA (30) | 994.50 | Sell |
| EMA (50) | 1,091.10 | Sell |
| EMA (100) | 1,198.55 | Sell |
| EMA (200) | 1,210.99 | Sell |
Daily Oscillators
| Name | Value | Action |
|---|---|---|
| Relative Strength Index (14) | 30.47 | Neutral |
| Stochastic %K (14, 3, 3) | 12.73 | Neutral |
| Commodity Channel Index (20) | −54.09 | Neutral |
| Average Directional Index (14) | 44.14 | Neutral |
| Momentum (10) | −14.70 | Buy |
| MACD Level (12, 26) | −114.96 | Sell |
| Stochastic RSI Fast (3, 3, 14, 14) | 50.40 | Neutral |
| Williams Percent Range (14) | −78.65 | Neutral |
| Ultimate Oscillator (7, 14, 28) | 42.14 | Neutral |
NATCO Pharma Latest News & Events Affecting Share Price
02/20/2025
Natco Pharma shares fell to to a 52-week low of ₹790.6. The stock has fallen 36% in the last 10 days.
02/18/2025
NATCO Pharma has declared a third interim dividend of ₹1.50 per equity share (75% of the face value of ₹2 per share) for the financial year 2024-25.
02/15/2025
Nirmal Bang has given an “accumulate” rating to NATCO Pharma with a target price of ₹956 as Revlimid contribution, new launches, and reduced price pressure in the US support growth, but long-term visibility beyond Revlimid and CTPR remains uncertain.
02/12/2025
NATCO Pharma Q3 profit fell 37.8% to Rs 132.4 crore, and revenue also fell 37.4% to Rs 475 crore. The company is currently facing operational challenges and decreasing margins.
02/07/2025
NATCO Pharma shares have broken the ₹1,275 resistance level, which is a positive sign. The stock may rise with a potential target of ₹1,420-1,460 due to buying pressure and high volumes.
02/06/2025
NATCO Pharma shares rose 3.15% to ₹ 1,324, rising for the third consecutive day. The stock rose 54.09% in the last one year, which is better performance than NIFTY and Nifty Pharma. Although it declined by 0.18% in the last month, the trading volume has remained stable.
NATCO Pharma Share Price Target FAQ
What is the NATCO Pharma share price target tomorrow?
NATCO Pharma share price target for tomorrow is between ₹808.20 and ₹841.00.
What is the NATCO Pharma share price target 2025?
NATCO Pharma share price target for 2025 is between ₹1,095.34 and ₹1,426.84.
What is the NATCO Pharma share price target 2030?
NATCO Pharma share price target for 2030 is between ₹2,425.73 and ₹2,742.50.
Is it profitable to invest in NATCO Pharma share?
According to our profit calculator, buying NATCO Pharma shares five years ago was a profitable decision, as the shares have increased by 34.55%.
What affects the price of NATCO Pharma share?
The price action of NATCO Pharma share is affected by supply and demand in the market. There are many things that affect supply and demand, such as a company’s financial performance (revenue, earnings, and future growth prospects), the overall economy (interest rates, inflation, and GDP growth), industry trends, investor sentiment, and news or events related to the company or its sector. And sometimes global events, political developments, and regulatory changes can also impact and influence share prices.
Risk Disclaimer: Stock prices can be volatile. You should only invest in stocks that you are familiar with and where you understand the associated risks. You should carefully consider your investment experience, financial situation, investment objectives and risk tolerance and consult an independent financial adviser prior to making any investment. This material should not be considered as financial advice. Past performance is not a reliable indicator of future performance. The value of your investment can go down as well as up, and you may not get back the amount you invested. You are solely responsible for your investment decisions. Figw is not responsible for any losses you may incur.